Angiogenesis in cardiovascular disease: current status and therapeutic potential.
about
Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.Therapeutic angiogenesis: protein-based therapy for coronary artery disease.MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathwayHydrogen peroxide signaling in vascular endothelial cells.N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.
P2860
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@ast
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@en
type
label
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@ast
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@en
prefLabel
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@ast
Angiogenesis in cardiovascular disease: current status and therapeutic potential.
@en
P1433
P1476
Angiogenesis in cardiovascular disease: current status and therapeutic potential
@en
P2093
F W Sellke
P304
P356
10.2165/00003495-199958030-00001
P577
1999-09-01T00:00:00Z
P6179
1017109956